Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
0.8690
+0.0485 (5.91%)
May 2, 2025, 4:00 PM EDT - Market closed
DRMA's stock price has decreased by -82.57% in the past year and price targets may not have had time to catch up.
Dermata Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$6.00
Upside
+590.45%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $10 → $6 | Strong Buy | Maintains | $10 → $6 | +590.45% | Aug 21, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $240 → $60 | Strong Buy | Maintains | $240 → $60 | +6,804.49% | Mar 23, 2023 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $3,360 | Strong Buy | Initiates | $3,360 | +386,551.32% | Sep 21, 2021 |
| Maxim Group | Maxim Group | Strong Buy Initiates $2,160 | Strong Buy | Initiates | $2,160 | +248,461.57% | Sep 14, 2021 |